NYSE - Delayed Quote • USD
AptarGroup, Inc. (ATR)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 5:59 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 6 | 6 |
| Avg. Estimate | 1.36 | 1.43 | 5.18 | 5.7 |
| Low Estimate | 1.31 | 1.39 | 5.04 | 5.54 |
| High Estimate | 1.4 | 1.49 | 5.25 | 5.88 |
| Year Ago EPS | 1.23 | 1.39 | 4.78 | 5.18 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 6 | 6 |
| Avg. Estimate | 931.52M | 943.24M | 3.63B | 3.8B |
| Low Estimate | 920.5M | 927.6M | 3.54B | 3.64B |
| High Estimate | 937.9M | 954.2M | 3.7B | 3.92B |
| Year Ago Sales | 898.79M | 908.53M | 3.49B | 3.63B |
| Sales Growth (year/est) | 3.60% | 3.80% | 4.10% | 4.60% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 1.14 | 1.27 | 1.12 | 1.15 |
| EPS Actual | 1.23 | 1.39 | 1.21 | 1.26 |
| Difference | 0.09 | 0.12 | 0.09 | 0.11 |
| Surprise % | 7.90% | 9.40% | 8.00% | 9.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.36 | 1.43 | 5.18 | 5.7 |
| 7 Days Ago | 1.36 | 1.43 | 5.19 | 5.71 |
| 30 Days Ago | 1.36 | 1.43 | 5.19 | 5.71 |
| 60 Days Ago | 1.36 | 1.43 | 5.19 | 5.71 |
| 90 Days Ago | 1.33 | 1.42 | 5.13 | 5.7 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | ATR | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 10.60% | -- | -- | 6.50% |
| Next Qtr. | 2.90% | -- | -- | 12.00% |
| Current Year | 8.40% | -- | -- | 5.30% |
| Next Year | 10.00% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 7.00% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 3.82% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Wells Fargo: Overweight to Overweight | 3/7/2024 |
| Upgrade | Baird: Neutral to Outperform | 1/3/2024 |
| Maintains | Wells Fargo: Overweight to Overweight | 9/11/2023 |
| Maintains | Wells Fargo: Overweight to Overweight | 7/17/2023 |
| Maintains | Deutsche Bank: Buy | 5/1/2023 |
| Maintains | Wells Fargo: Overweight | 5/1/2023 |
Related Tickers
UTMD Utah Medical Products, Inc.
65.92
-0.56%
ATRI Atrion Corporation
395.01
-0.99%
WST West Pharmaceutical Services, Inc.
360.43
-2.10%
COO The Cooper Companies, Inc.
88.84
-1.21%
MMSI Merit Medical Systems, Inc.
73.78
+0.55%
HAE Haemonetics Corporation
90.99
+3.80%
TFX Teleflex Incorporated
206.71
0.00%
ALC Alcon Inc.
78.77
-0.09%
ICUI ICU Medical, Inc.
94.84
+0.33%
LMAT LeMaitre Vascular, Inc.
65.46
+3.92%